Edition:
United States

Aslan Pharmaceuticals Qtrly Basic Loss Per Share $0.07


Friday, 22 Mar 2019 11:12am EDT 

March 22 (Reuters) - Aslan Pharmaceuticals Ltd <6497.TWO>::ASLAN PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.ASLAN PHARMACEUTICALS LTD QTRLY BASIC LOSS PER SHARE $0.07.ASLAN PHARMACEUTICALS - CASH, CASH EQUIVALENTS & SHORT-TERM INVESTMENTS TOTALED $28.9 MILLION AS OF DEC. 31, 2018 VERSUS $50.6 MILLION AS OF DEC. 31, 2017. 

Company Quote

24.5
0.2 +0.82%
1:30am EDT